AVN944 in Combination With Gemcitabine for the Treatment of Pancreatic Cancer
Status:
Terminated
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The study was designed to find the optimum AVN944 dose to use in combination with gemcitabine
in patients with pancreatic cancer and see if the combination of the 2 drugs was more
effective for treating pancreatic cancer than using gemcitabine alone.